14.45

2.90% -0.4313

After Hours: 14.45 0.005 +0.03%

Palatin Technologies Inc. (PTN)

Overview News Price History Option Chain Discussions Forecast Stock Split

Palatin Technologies Inc. stock is traded at $14.45, with a volume of 12,383. It is down -2.90% in the last 24 hours and down -34.99% over the past month. Palatin Technologies, Inc., a biopharmaceutical company, develops targeted, receptor-specific therapeutics for the treatment of various diseases in the United States. The company's principal product is Vyleesi, an on demand subcutaneous injectable product that has completed Phase III clinical studies for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. Its drug development programs also include melanocortin receptor system program, such as PL-8177, a selective melanocortin receptor 1 agonist peptide for inflammatory bowel diseases; and PL-8331, a preclinical development candidate for treating ocular inflammation, as well as melanocortin receptor 4 peptides and orally-active small molecules to treat genetic metabolic and obesity disorders. In addition, the company develops natriuretic peptide receptor systems comprising PL3994, a natriuretic peptide receptor-A agonist, which has completed Phase I clinical study for the treatment of cardiovascular indications; and PL-5028, a dual natriuretic peptide receptor A and C agonist that is in preclinical development for cardiovascular diseases, such as reducing cardiac hypertrophy and fibrosis. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.

Previous Close:

$14.88

Open:

$14.81

24h Volume:

12,383

Relative Volume:

0.79

Market Cap:

$25.70M

Revenue:

$8.96M

Net Income/Loss:

$-9.63M

P/E Ratio:

-12.21

EPS:

-1.1831

Net Cash Flow:

$-15.88M

1W Performance:

+1.23%

1M Performance:

-34.99%

6M Performance:

-14.93%

1Y Performance:

+15,251%

1-Day Range:

$13.97

$14.81

1-Week Range:

$13.97

$15.01

52-Week Range:

$7.25

$31.00

Palatin Technologies Inc. Stock (PTN) Company Profile

Name

Palatin Technologies Inc.

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

609-495-2200

Address

Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ

Employee

Twitter

@PalatinTech

Next Earnings Date

2026-05-13

Latest SEC Filings

PTN's Discussions on Twitter

Compare PTN vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PTN Palatin Technologies Inc.	14.45	26.47M	8.96M	-9.63M	-15.88M	-1.1831
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-12-25	Initiated	Laidlaw	Buy
Dec-03-25	Initiated	Alliance Global Partners	Buy
Jun-05-15	Reiterated	Canaccord Genuity	Buy
Jan-12-15	Reiterated	ROTH Capital	Buy
May-23-12	Initiated	Noble Financial	Buy
Jan-23-07	Initiated	Next Generation	Buy

View All

Palatin Technologies Inc. Stock (PTN) Latest News

May 23, 2026

Q1 2026 Palatin Technologies Inc Earnings Call Transcript - GuruFocus

May 23, 2026

May 22, 2026

PTN Technical Analysis | Trend, Signals & Chart Patterns | PALATIN TECHNOLOGIES INC (NYSEARCA:PTN) - ChartMill

May 22, 2026

May 19, 2026

Palatin Technologies to Transfer Stock Listing from NYSE American to Nasdaq Capital Market on May 29, 2026 - Minichart

May 19, 2026

Palatin Technologies to transfer listing to Nasdaq from NYSE By Investing.com - Investing.com South Africa

May 19, 2026

May 18, 2026

Palatin Technologies Announced Transfer or Voluntary Withdrawal of Listing - TradingView

May 18, 2026

Palatin Technologies (NYSE: PTN) plans move to Nasdaq Capital Market - Stock Titan

May 18, 2026

Palatin Technologies to transfer listing to Nasdaq from NYSE - Investing.com

May 18, 2026

Palatin to Begin Trading on Nasdaq Stock Exchange - Moomoo

May 18, 2026

Palatin Technologies Earnings Call: Partnerships, Progress, Risks - TipRanks

May 18, 2026

May 17, 2026

Palatin Technologies, Inc. Announces Receipt of NYSE American No - GuruFocus

May 17, 2026

May 15, 2026

Logos Global files Schedule 13G/A: 182,162 shares (PTN) reported on May 12, 2026 - Stock Titan

May 15, 2026

Point72/Steven A. Cohen disclose 8,600 PTN shares (0.5%) — PTN - Stock Titan

May 15, 2026

Sirenia Capital / Alex Silverstein report 2.3M PTN shares (PTN) - Stock Titan

May 15, 2026

May 14, 2026

Palatin Technologies 3Q Loss/Shr 37c >PTN - Moomoo

May 14, 2026

Palatin Technologies stock (US69608A1088): Q3 revenue jumps to $3.9M, loss narrows - AD HOC NEWS

May 14, 2026

A. G. P. Maintains Palatin Technologies(PTN.US) With Buy Rating, Cuts Target Price to $47.5 - Moomoo

May 14, 2026

Palatin Technologies, Inc. (AMEX:PTN) Q3 2026 Earnings Call Transcript - Insider Monkey

May 14, 2026

Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - Sahm

May 14, 2026